Company Tagline
Bringing innovative therapies to patients
Industry Category
Business Keywords
Company Description
Draupnir Bio is a pioneering biotechnology company dedicated to bringing innovative therapies to patients. Driven by a deep commitment to scientific excellence, Draupnir Bio is at the forefront of developing oral, small molecule degraders of extracellular pathogenic proteins. This novel approach represents the next frontier of targeted protein degradation (TPD), a rapidly emerging field that harnesses a cell’s own destruction machinery to tackle disease-causing proteins.
Draupnir Bio's proprietary technology platform targets lysosome receptors, extending the potential of TPD to both extracellular and membrane-bound proteins, which comprise a significant portion of the human proteome. This pioneering approach has the potential to revolutionize the field of TPD. With headquarters in Copenhagen, DK, and additional facilities in Aarhus, DK, Draupnir Bio is strategically positioned to advance its groundbreaking research.
Backed by a syndicate of leading European investors, Draupnir Bio is committed to transforming the landscape of targeted protein degradation. Draupnir Bio's innovative therapies hold immense promise for addressing previously intractable diseases. We invite the management of Draupnir Bio to create a customized and exclusive company showcase and product listing on our platform to further highlight their advancements.
Draupnir Bio er et banebrydende bioteknologisk firma dedikeret til at bringe innovative terapier til patienter. Drevet af en dyb forpligtelse til videnskabelig ekspertise er Draupnir Bio på forkant med udviklingen af orale, småmolekylære nedbrydere af ekstracellulære patogene proteiner. Denne nye tilgang repræsenterer den næste grænse inden for målrettet proteinnedbrydning (TPD), et hurtigt voksende felt, der udnytter en celles egen destruktionsmekanisme til at tackle sygdomsfremkaldende proteiner.
Draupnir Bios proprietære teknologiplatform er rettet mod lysosomreceptorer og udvider potentialet for TPD til både ekstracellulære og membranbundne proteiner, som udgør en betydelig del af det menneskelige proteom. Denne banebrydende tilgang har potentiale til at revolutionere feltet TPD. Med hovedkvarter i København, DK, og yderligere faciliteter i Aarhus, DK, er Draupnir Bio strategisk positioneret til at fremme sin banebrydende forskning.
Støttet af et syndikat af førende europæiske investorer er Draupnir Bio engageret i at transformere landskabet for målrettet proteinnedbrydning. Draupnir Bios innovative terapier rummer et enormt løfte om at adressere tidligere uhåndterlige sygdomme. Vi inviterer ledelsen i Draupnir Bio til at skabe et skræddersyet og eksklusivt firmashowcase og produktliste på vores platform for yderligere at fremhæve deres fremskridt.
Key Personnel / Employees
Compare Companies Side by Side
Compare Draupnir Bio with 3 companies in Biotechnology-Research
| Comparison Field |
Draupnir BioMain Company |
Blackrock NeurotechView Profile |
Regenerative Medicin...View Profile |
BEEI a Pion CompanyView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2008 | 2003 | 1994 |
|
Company Size
|
— | 51-200 | 2-10 | 11-50 |
|
City
|
Salt Lake City, Utah | Wellington, FL | South Easton, MA | |
|
Country
|
United States | United States | ||
|
Skills & Keywords
Comparing with main company
|
13 Total Skills
Biotechnology
Targeted Protein Degradation
Lysosome
Extracellular Proteins
Small Molecule Degraders
Drug Development
Pharmaceuticals
targeted protein degradation
biotech
lysosome
extracellular targets
membrane-bound proteins
biotechnology
|
21 Total
21 Unique
Unique Skills:
bci
brain chip
brain computer interface
brain-computer interface
Communication
medical devices
+15
|
11 Total
11 Unique
Unique Skills:
advocacy
education
ethics
investment
legal
non-profit
+5
|
20 Total
20 Unique
Unique Skills:
cannabinoids
cannabis
cell disruption
cell lysing
food sciences
graphene
+14
|
4
Total Companies1994
Oldest Founded1
Countries65
Unique SkillsSimilar Companies
Other organizations in the same industry
CereCura Nanotherapeutics
Biotechnology-ResearchTreating brain disease from within
C16 Biosciences
Biotechnology-ResearchC16 Biosciences produces high-performance biodesigned ingredients for the personal care, home care,...
Alternative Company Names
This company is also known as